Lithuanian national focal point
The national focal point in Lithuania is situated within the Drug, Tobacco and Alcohol Control Department of the Government of the Republic of Lithuania. The main responsibilities of the department include implementation of the national drug programme, information gathering and dissemination. The department operates under the leadership of the Prime Minister and Minister of Health and is responsible for relations with international organisations, including the EMCDDA.
News
Events
Publications
Publications related to this partner
The elimination barometer for hepatitis B and C among people who inject drugs is designed to support countries affiliated to the EMCDDA in monitoring their progress towards the Sustainable Development Goal 3.3 and the elimination of viral hepatitis as a major public health threat by 2030.
Heroin remains Europe’s most commonly used illicit opioid and is also the drug responsible for a large share of the health burden attributed to illicit drug consumption.
MDMA is a synthetic drug chemically related to the amphetamines, but with somewhat different effects. In Europe, MDMA use has generally been associated with episodic patterns of consumption in the context of nightlife and entertainment settings.
Amphetamine, methamphetamine and, more recently, synthetic cathinones are all synthetic central nervous system stimulants available on the drug market in Europe.
The market for new psychoactive substances is characterised by the large number of substances that have appeared in this area and that new compounds continue to be detected each year.
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe.
Document library
Media library
Related photos, infographics and videos from our Media library
Contact information
Drug, Tobacco and Alcohol Control Department
Ms Brigita Rasimaite
Vilnius
Lithuania